mmunic’s shares jumped 27% after it raised up to $400 million to advance its multiple sclerosis drug trials, announced leadership changes, and emphasized efforts to go commercial.
https://www.tipranks.com/news/why-is-immunic-stock-imux-up-26-today
mmunic’s shares jumped 27% after it raised up to $400 million to advance its multiple sclerosis drug trials, announced leadership changes, and emphasized efforts to go commercial.
https://www.tipranks.com/news/why-is-immunic-stock-imux-up-26-today
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.